Kiryushko Darya, Kofoed Thomas, Skladchikova Galina, Holm Arne, Berezin Vladimir, Bock Elisabeth
Protein Laboratory, Institute of Molecular Pathology, Panum Institute Bldg. 6.2, Blegdamsvej 3C, DK-2200, Copenhagen N, Denmark.
J Biol Chem. 2003 Apr 4;278(14):12325-34. doi: 10.1074/jbc.M211628200. Epub 2002 Dec 26.
The neural cell adhesion molecule (NCAM) plays a key role in morphogenesis of the nervous system and in remodeling of neuronal connections accompanying regenerative and cognitive processes. Recently, a new synthetic ligand of NCAM, the C3-peptide, which binds to the NCAM IgI module, has been identified by means of combinatorial chemistry (Rønn, L. C. B, Olsen, M., Ostergaard, S., Kiselyov, V., Berezin, V., Mortensen, M. T., Lerche, M. H., Jensen, P. H., Soroka, V., Saffell, J. L., Doherty, P., Poulsen, F. M., Bock, E., Holm, A., and Saffells, J. L. (1999) Nat. Biotechnol. 17, 1000-1005). In vitro, the dendrimeric form of C3, termed C3d, disrupts NCAM-mediated cell adhesion, induces neurite outgrowth, and triggers intracellular signaling cascades similar to those activated by homophilic NCAM binding. The peptide may therefore be expected to regulate regeneration and synaptic plasticity. Here we demonstrate that in primary cultures of hippocampal neurons: 1) C3d induces a sustained neuritogenic response, the neuritogenic activity of the compound being dependent on the dose, starting time, and duration of peptide application; 2) the peptide triggers the neuritogenic response by forming an adhesive substratum necessary for NCAM-mediated neurite formation and elongation; 3) C3d promotes synapse formation; and 4) C3d modulates the presynaptic function, causing a transient increase of the function at low (2 and 5 microm) doses and a reduction when applied at a higher concentration (10 microm). The effect of the peptide is dependent on the activation of the fibroblast growth factor receptor. We suggest that C3d may constitute a useful lead for the development of compounds for treatment of various neurodegenerative disorders.
神经细胞黏附分子(NCAM)在神经系统的形态发生以及伴随再生和认知过程的神经元连接重塑中起着关键作用。最近,通过组合化学方法鉴定出了一种新的NCAM合成配体,即C3肽,它与NCAM IgI模块结合(Rønn, L. C. B, Olsen, M., Ostergaard, S., Kiselyov, V., Berezin, V., Mortensen, M. T., Lerche, M. H., Jensen, P. H., Soroka, V., Saffell, J. L., Doherty, P., Poulsen, F. M., Bock, E., Holm, A., and Saffells, J. L. (1999) Nat. Biotechnol. 17, 1000 - 1005)。在体外,C3的树枝状聚合物形式,即C3d,可破坏NCAM介导的细胞黏附,诱导神经突生长,并触发类似于由同源NCAM结合激活的细胞内信号级联反应。因此,该肽有望调节再生和突触可塑性。在此我们证明,在海马神经元的原代培养中:1)C3d诱导持续的神经突生成反应,该化合物的神经突生成活性取决于剂量、起始时间和肽应用的持续时间;2)该肽通过形成NCAM介导的神经突形成和伸长所必需的黏附基质来触发神经突生成反应;3)C3d促进突触形成;4)C3d调节突触前功能,在低剂量(2和5微摩尔)时导致功能短暂增加,而在高浓度(10微摩尔)应用时导致功能降低。该肽的作用取决于成纤维细胞生长因子受体的激活。我们认为C3d可能是开发用于治疗各种神经退行性疾病的化合物的有用先导物。